Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mineral and Bone Disease in CKD and Kidney Transplantation: Controversies, Gaps, and a Path Forward.

Kidney international reports·2026
Same author

Perivascular fat, hypertension, and cardiovascular disease.

Kidney international·2026
Same author

French nephrologists’ practices in the management of anemia and iron deficiency in chronic kidney disease

Nephrologie & therapeutique·2026
Same author

Mechanism of reduced intestinal phosphate absorption by tenapanor: a hypothesis.

Clinical kidney journal·2026
Same author

Contribution of genetic variants to nephrolithiasis.

Kidney international·2025
Same author

A longitudinal analysis of haemoglobin levels and major cardiovascular events.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025

Related Experiment Video

Updated: Jun 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Atherosclerosis in CKD: differences from the general population.

Tilman B Drüeke1, Ziad A Massy

  • 1Inserm ERI-12, UFR de Médecine et de Pharmacie, Université de Picardie Jules Verne, 80037 Amiens, France. tilman.drueke@inserm.fr

Nature Reviews. Nephrology
|October 28, 2010
PubMed
Summary

Cardiovascular disease is more common in chronic kidney disease (CKD) patients. Atherosclerosis is aggravated by CKD, increasing the fatality of cardiovascular events.

More Related Videos

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

Related Experiment Videos

Last Updated: Jun 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

Area of Science:

  • Nephrology
  • Cardiology
  • Pathophysiology

Background:

  • Cardiovascular morbidity and mortality are significantly higher in patients with chronic kidney disease (CKD), particularly end-stage renal disease.
  • The precise role of atherosclerosis in CKD-related cardiovascular disease has been debated, with early theories emphasizing its primary role and accelerated progression due to uremia.
  • More recent research suggests other mechanisms like arteriosclerosis, vascular calcification, and cardiac myocyte issues are also involved.

Purpose of the Study:

  • To clarify the contribution of atherosclerosis to cardiovascular disease in patients with chronic kidney disease (CKD).
  • To elucidate the interplay between CKD, aging, and the development and progression of cardiovascular abnormalities.

Main Methods:

  • Review of clinical and experimental findings.
  • Analysis of imaging and morphological studies related to cardiovascular disease in CKD.
  • Hypothesis formulation based on existing evidence.

Main Results:

  • Initial cardiovascular abnormalities in CKD include arteriosclerosis, left ventricular diastolic dysfunction, and hypertrophy.
  • Atherosclerosis prevalence increases with age and is aggravated, but not solely induced, by CKD.
  • Cardiovascular events linked to atherosclerosis are more frequently fatal in CKD patients.

Conclusions:

  • CKD aggravates atherosclerosis, contributing to increased cardiovascular event fatality.
  • Arteriosclerosis and ventricular dysfunction are key early cardiovascular changes in CKD.
  • Understanding these mechanisms is crucial for managing cardiovascular risk in CKD patients.